Literature DB >> 1282476

Recent studies on retrovirus-like particles in Chinese hamster ovary cells.

M Dinowitz1, Y S Lie, M A Low, R Lazar, C Fautz, B Potts, J Sernatinger, K Anderson.   

Abstract

Highly concentrated (4000-7000-fold) culture fluids from CHO cells were analysed for the presence of retrovirus-like activity. Concentrates containing reverse transcriptase activity were detected and further purified by sucrose density gradient centrifugation. Particles banding at 1.13-1.16 g/ml were found to contain nucleic acid sequences and structural proteins related to those found in murine and other retroviruses. Analysis of the endonuclease gene has shown no intact open reading frames. Approximately 100-300 copies of the C-type sequences were present in the genome of CHO cell lines as well as in the DNA extracted from Chinese hamster liver, indicating that these sequences are present in the germ line of the species. Concentrates were analysed for infectivity by direct inoculation and co-cultivation with a series of detector cells. No evidence of infectivity was detected by reverse transcriptase, mink cell S+L- focus assay or by electron microscopic analysis of the inoculated detector cells after at least four passages in culture.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1282476

Source DB:  PubMed          Journal:  Dev Biol Stand        ISSN: 0301-5149


  9 in total

1.  Viral validation strategy for recombinant products derived from established animal cell lines.

Authors:  P J Shadle; P R McAllister; T M Smith; A S Lubiniecki
Journal:  Cytotechnology       Date:  1995-01       Impact factor: 2.058

2.  Retroviral membrane display of apoptotic effector molecules.

Authors:  D Strehlow; S Jodo; S T Ju
Journal:  Proc Natl Acad Sci U S A       Date:  2000-04-11       Impact factor: 11.205

3.  Proteogenomic Annotation of Chinese Hamsters Reveals Extensive Novel Translation Events and Endogenous Retroviral Elements.

Authors:  Shangzhong Li; Seong Won Cha; Kelly Heffner; Deniz Baycin Hizal; Michael A Bowen; Raghothama Chaerkady; Robert N Cole; Vijay Tejwani; Prashant Kaushik; Michael Henry; Paula Meleady; Susan T Sharfstein; Michael J Betenbaugh; Vineet Bafna; Nathan E Lewis
Journal:  J Proteome Res       Date:  2019-05-08       Impact factor: 4.466

4.  Chinese hamster ovary cells contain transcriptionally active full-length type C proviruses.

Authors:  Y S Lie; E M Penuel; M A Low; T P Nguyen; J O Mangahas; K P Anderson; C J Petropoulos
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

5.  Detection and cloning of LINE-1 elements in CHO cells.

Authors:  Olga Piskareva; Martin Clynes; Niall Barron
Journal:  Cytotechnology       Date:  2007-03-03       Impact factor: 2.058

6.  Combating viral contaminants in CHO cells by engineering innate immunity.

Authors:  Austin W T Chiang; Shangzhong Li; Benjamin P Kellman; Gouri Chattopadhyay; Yaqin Zhang; Chih-Chung Kuo; Jahir M Gutierrez; Faezeh Ghazi; Hana Schmeisser; Patrice Ménard; Sara Petersen Bjørn; Bjørn G Voldborg; Amy S Rosenberg; Montserrat Puig; Nathan E Lewis
Journal:  Sci Rep       Date:  2019-06-20       Impact factor: 4.379

7.  Characterization and mutagenesis of Chinese hamster ovary cells endogenous retroviruses to inactivate viral particle release.

Authors:  Pierre-Olivier Duroy; Sandra Bosshard; Emanuel Schmid-Siegert; Samuel Neuenschwander; Ghislaine Arib; Philippe Lemercier; Jacqueline Masternak; Lucien Roesch; Flavien Buron; Pierre-Alain Girod; Ioannis Xenarios; Nicolas Mermod
Journal:  Biotechnol Bioeng       Date:  2019-11-12       Impact factor: 4.530

8.  Filter preconditioning enables representative scaled-down modelling of filter capacity and viral clearance by mitigating the impact of virus spike impurities.

Authors:  Navid Z Khan; Joseph J Parrella; Paul W Genest; Michael S Colman
Journal:  Biotechnol Appl Biochem       Date:  2009-04       Impact factor: 2.431

9.  Virus contaminations of cell cultures - A biotechnological view.

Authors:  O-W Merten
Journal:  Cytotechnology       Date:  2002-07       Impact factor: 2.058

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.